The Target ALS Annual Meeting is pleased to offer a mobile app.
Instructions to download the application will be provided to all registered participants on April 27, 2023

Networking Meetings

Networking meetings can be booked using the Target ALS mobile app, which will be released on April 27.  Anyone participating in the annual meeting (in-person or virtual) can request a private 1:1 meeting with a participant through the mobile app, The current registrant directory can be reviewed below.

Marissa Udine Marissa Udine
Bristol-Myers Squibb
Virtual Attendee
Emem Udo Emem Udo
mgh
Clinical Project Manager
Virtual Attendee
Sharanya Unnikrishnan Sharanya Unnikrishnan
Regeneron Pharmaceuticals
Sr Associate Scientist
Virtual Attendee
Philip Van Damme Prof. Philip Van Damme
KU Leuven
Neurologist
Virtual Attendee
Andrea Vandelli Andrea Vandelli
UAB
Virtual Attendee
Ludo Van Den Bosch Dr. Ludo Van Den Bosch
University of Leuven, Belgium
Virtual Attendee
Christine Vande Velde Dr. Christine Vande Velde
University of Montreal
Professor
Virtual Attendee
Bijal Vanjara Bijal Vanjara
Neumora Therapeutics
Virtual Attendee
Jose Norberto Sagullo (Jobert) Vargas Dr Jose Norberto Sagullo (Jobert) Vargas
UCL (Institute of Neurology); UKDRI
Postdoctoral Fellow
Virtual Attendee
Fernando Vieira Fernando Vieira
ALS Therapy Development Institute
CEO/CSO
Virtual Attendee
Brian Wainger Dr. Brian Wainger
Massachusetts General Hospital
Virtual Attendee
Safal Walia Mr. Safal Walia
Helmholtz Munich
Doctoral Researcher
Virtual Attendee